Skip to main content
Sisram Medical Ltd logo

Sisram Medical Ltd — Investor Relations & Filings

Ticker · 1696 ISIN · IL0011418113 HKEX Manufacturing
Open in API
Filings indexed 1,569 across all filing types
Latest filing 2025-03-21 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1696

About Sisram Medical Ltd

http://www.sisram-medical.com

Sisram Medical Ltd. is a global consumer wellness group specializing in medical aesthetics and minimally invasive solutions. Leveraging over two decades of expertise, the company is a leader in Energy-Based Devices (EBD), harnessing natural energy sources for both aesthetic and medical clinical indications. Sisram operates through a synergistic ecosystem of brands, providing medical-grade quality solutions to professional customers and consumers worldwide. Key segments include Alma, a provider of energy-based solutions for surgical and medical aesthetics markets; LMNT, a personal care brand for home use; Copulla, which offers end-to-end digital dentistry services; and a dedicated injectables portfolio. The company's extensive product range covers treatments such as hair removal, skin rejuvenation, body contouring, and dermal fillers.

Recent filings

Filing Released Lang Actions
DISCLOSEABLE TRANSACTION - SUBSCRIPTION OF FUND
Regulatory Filings Classification · 79% confidence The document is a Hong Kong Exchange announcement regarding a discloseable transaction (a subscription of HK$30 million into a segregated portfolio fund) under Listing Rules Chapter 14. It is not an AGM presentation, no financial results are reported, and it is not a report publication announcement. It is a regulatory announcement of a corporate transaction that does not fit the other specific categories, so it falls into the general regulatory filings category (RNS).
2025-03-21 English
FINAL DIVIDEND FOR THE YEAR ENDED DECEMBER 31, 2024
Notice of Dividend Amount Classification · 94% confidence The document is an announcement of a final cash dividend by Sisram Medical Ltd for the year ended December 31, 2024, including per-share amount, record dates, payment dates, and share registrar details. This matches a Notice of Dividend Amount (DIV).
2025-03-19 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024
Interim / Quarterly Report Classification · 95% confidence The document is an 'Annual Results Announcement' for Sisram Medical Ltd for the year ended December 31, 2024. It contains comprehensive financial statements, including the Consolidated Statement of Profit or Loss, Consolidated Statement of Comprehensive Income, and Consolidated Statement of Financial Position, along with detailed notes to the financial statements. While it is titled an 'Announcement', it provides the full substantive financial data and analysis for the fiscal year, which aligns with the definition of an Interim/Quarterly Report (IR) in the context of periodic financial reporting, or more specifically, an Annual Results report. Given the provided categories, 'IR' is the most appropriate classification for a comprehensive financial report covering a specific period, as it contains the actual financial statements and analysis. FY 2024
2025-03-19 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 95% confidence The document is an announcement listing the members of the board of directors, their roles, and committee memberships effective a specific date. This directly fits the “Board/Management Information” category (Code: MANG), which covers announcements of changes in the company's board or senior management.
2025-03-19 English
APPOINTMENT OF DIRECTOR
Board/Management Information Classification · 80% confidence The document is an announcement from a listed company’s board regarding the appointment of a new director (Mr. Jiahong Li). It details his background, term, and related disclosures. This falls under Board/Management Information (MANG).
2025-03-19 English
Date of Board Meeting
Regulatory Filings Classification · 81% confidence The document is a short announcement from Sisram Medical Ltd notifying investors of a board meeting date to consider and approve year-end results and dividend recommendation. It does not contain actual financial results or the report itself, nor is it a shareholder meeting notice or change of management. It is an announcement under Hong Kong listing rules of a board meeting, which does not fit any specific category like Annual Report, Earnings Release, or Board/Management change. Therefore, it falls under the general "Regulatory Filings" fallback category (RNS).
2025-03-07 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.